The group wants to consider potential collaborations in China and opportunities in Australia. The influential China Entrepreneur Club, which counts Alibaba founder Jack Ma in its invitation-only membership, have a delegation in Australia this week. The limitations faced by CSL in this regard was a key topic of discussion between the chairman and a delegation of uber-rich Chinese business people who visited the company's Melbourne manufacturing plant on Thursday. The company, which pierced a market capitalisation of $40 billion this week, faces the obstacle of building a network of collection centres, not to mention regulatory change, if it were to supply other blood and plasma products in China. Although the free trade agreement will not have a "practical" impact on this business, Professor Shine said it would facilitate better relationships. The company had revenue of about $US300 million from China in 2013-14, which surged 29 per cent on the prior year. It has about 120 staff in the country and has a burgeoning business supplying the blood protein albumin to hospitals for use treating burns victims and replacing fluid lost during surgery. "It's been supported by their government and so they're keen to explore various avenues using that."ĬSL has been in China for over a decade. "It's on their agenda, it's upfront," he said.
0 Comments
Leave a Reply. |